Quantbot Technologies LP boosted its position in shares of Albemarle Corporation (NYSE:ALB – Free Report) by 106.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 178,788 shares of the specialty chemicals company’s stock after acquiring an additional 92,175 shares during the period. Quantbot Technologies LP owned 0.15% of Albemarle worth $12,876,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Nuveen LLC purchased a new position in Albemarle during the 1st quarter worth $26,836,000. Dimensional Fund Advisors LP grew its stake in Albemarle by 28.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,538,706 shares of the specialty chemicals company’s stock worth $110,814,000 after buying an additional 343,210 shares during the last quarter. Manning & Napier Advisors LLC grew its stake in Albemarle by 17.4% during the 1st quarter. Manning & Napier Advisors LLC now owns 1,167,520 shares of the specialty chemicals company’s stock worth $84,085,000 after buying an additional 173,441 shares during the last quarter. GAMMA Investing LLC grew its stake in Albemarle by 6,393.1% during the 1st quarter. GAMMA Investing LLC now owns 152,394 shares of the specialty chemicals company’s stock worth $10,975,000 after buying an additional 150,047 shares during the last quarter. Finally, Man Group plc grew its stake in Albemarle by 1,213.0% during the 4th quarter. Man Group plc now owns 158,649 shares of the specialty chemicals company’s stock worth $13,657,000 after buying an additional 146,566 shares during the last quarter. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on ALB shares. Robert W. Baird restated an “underperform” rating and set a $60.00 target price on shares of Albemarle in a research note on Tuesday, July 29th. Morgan Stanley decreased their price target on shares of Albemarle from $68.00 to $58.00 and set an “underweight” rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company decreased their price target on shares of Albemarle from $75.00 to $70.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. KeyCorp reaffirmed a “sector weight” rating on shares of Albemarle in a report on Wednesday, July 30th. Finally, TD Securities decreased their price target on shares of Albemarle from $115.00 to $65.00 and set a “hold” rating for the company in a report on Thursday, May 1st. Five analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $88.06.
Albemarle Stock Up 0.9%
ALB stock opened at $82.18 on Monday. The firm has a market cap of $9.67 billion, a PE ratio of -8.82 and a beta of 1.63. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.47 and a current ratio of 2.31. The firm’s fifty day moving average is $69.53 and its 200 day moving average is $67.83. Albemarle Corporation has a one year low of $49.43 and a one year high of $113.91.
Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The specialty chemicals company reported $0.11 EPS for the quarter, beating the consensus estimate of ($0.83) by $0.94. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.23 billion. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The firm’s revenue was down 7.0% on a year-over-year basis. During the same quarter last year, the business earned $0.04 earnings per share. On average, research analysts forecast that Albemarle Corporation will post -0.04 EPS for the current year.
Albemarle Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, September 12th will be given a $0.405 dividend. The ex-dividend date is Friday, September 12th. This represents a $1.62 annualized dividend and a dividend yield of 2.0%. Albemarle’s dividend payout ratio (DPR) is -17.38%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More
- Five stocks we like better than Albemarle
- What Investors Need to Know to Beat the Market
- Next-Gen Defense: 3 Stocks Riding the New Global Arms Race
- Overbought Stocks Explained: Should You Trade Them?
- Travel Stocks Rally on Earnings—More Upside Ahead?
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Silver Prices Up, But Endeavour’s Profit Still Elusive
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.